Myogenes News & Blog
Get the latest pharmacogenomics, DNA testing and genetics news.
How treatment for ADHD can be personalised with genetic testing
After watching your child struggle for months to sit still or maintain focus, it can be a relief to hear that your child has attention-deficit/hyperactivity disorder (ADHD). You may have a few more hurdles to jump if your child's clinician recommends ADHD medication....
Pharmacogenomic Testing:
What is it and who should get it?
Recent decades have seen a rise in precision (or personalised) medicine due to rapid advances in genetics and a better understanding of the human brain and body. There is no guarantee that two people will respond to the same medication, even if they have similar...
Matching drugs to DNA is ‘new era of medicine’
We have the technology to start a new era in medicine by precisely matching drugs to people’s genetic code, a major report says. Some drugs are completely ineffective or become deadly because of subtle differences in how our bodies function. The British...
Experts push genetic testing for drug prescriptions
Pharmacogenomic testing could save the NHS money in the long term and reduce the risks of side-effects. Genetic testing to predict how individuals will respond to common medicines should be implemented without delay to reduce the risk of side-effects and ensure that...
Getting Pharmacogenomics into the Clinic
Getting Pharmacogenomicsinto the Clinic This Medical News Article Discusses Barriers to Widespread Implementation of Genotype-Guided Prescribing What if there were a way to know if a depressed patient would respond to an antidepressant—before it was prescribed? Or to...
Polygenic Risk Score Predicts Statin Response
Polygenic Risk Score Predicts Statin Response Harlan M. Krumholz, MD, SM ReviewingNatarajan P et al. Another stride towards personalised medicine through Statins response. The aspiration of precision medicine is to personalize our approach to individual patients. One...
Personalised Healthcare For All
Speak to one of our advisors today